Eden Venti

Eden Venti, M.S., RQAP-GCP has extensive experience in quality assurance and regulatory affairs. They currently hold the position of Vice President of Quality at BioTissue. Prior to this, they worked as an Independent Quality Advisor for the biotech industry. At axogen, they served as the Vice President of Quality from 2019 to 2021. Eden also held the position of Director of Global Quality Assurance at Philip Morris International from 2016 to 2019. They have further experience as a Principal Consultant at NSF Health Sciences, Director of Global Quality, Health & Nutrition at FMC Corporation, and Head of Quality Systems at AstraZeneca Global Operations-Supply Biologics. They also worked as the Senior Vice President of Quality at MasterControl and as the Director of QA at Incyte. Eden's early career includes serving as the Head of Quality Assurance and Regulatory Affairs at Wedgewood Pharmacy.

Eden Venti, M.S., RQAP-GCP has a diverse education history. In 2021, they obtained a Certificate in Quantum Science and Technology from the Pritzker School of Molecular Engineering at the University of Chicago. The following year, they acquired the RQAP-GCP certification from the Society of Quality Assurance. In 2020, Eden completed a Leadership in a Crisis program at INSEAD and earned a Certificate in MIT Sloan Artificial Intelligence: Implications for Business Strategy from MIT Sloan Executive Education. Their previous academic achievements include a Master's degree in QA/RA from Temple University (2003-2007) and a Bachelor of Arts (B.A.) from the University of Delaware (1989-1994). Additionally, Eden has a Diploma in Chemistry Technology from Delaware Technical Community College. They also hold various certifications, including Facilitative Leadership and Interpretation and Application of ICH E6(R2) Version 1.0.